What Role Is There for Antithymocyte Globulin in Allogeneic Nonmyeloablative Canine Hematopoietic Cell Transplantation?

This publication has 41 references indexed in Scilit:

• Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow
  Blood, 2003
• HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies
  Blood, 2003
• Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML
  Bone Marrow Transplantation, 2003
• FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease1
  Transplantation, 2003
• WHAT ROLE FOR FTY720, A NOVEL IMMUNOSUPPRESSIVE AGENT, IN CANINE NONMYELOABLATIVE HEMATOPOIETIC STEM CELL TRANSPLANTATION?1
  Transplantation, 2002
• Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies
  Transplantation and Cellular Therapy, 2000
• HISTOCOMPATIBILITY TESTING OF DOG FAMILIES WITH HIGHLY POLYMORPHIC MICROSATELLITE MARKERS1
  Transplantation, 1996
• USE OF (CA)n POLYMORPHISMS TO DETERMINE THE ORIGIN OF BLOOD CELLS AFTER ALLOGENEIC CANINE MARROW GRAFTING
  Transplantation, 1994
• Monoclonal antibodies specific for canine CD4 and CD8 define functional T‐lymphocyte subsets and high‐density expression of CD4 by canine neutrophils
  Tissue Antigens, 1992
• The canine major histocompatibility complex
  Tissue Antigens, 1983